Global Biologics Market Growth 2023-2029

Global Biologics Market Growth 2023-2029

A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.

LPI (LP Information)' newest research report, the “Biologics Industry Forecast” looks at past sales and reviews total world Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Biologics sales for 2023 through 2029. With Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Biologics industry.

This Insight Report provides a comprehensive analysis of the global Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Biologics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Biologics.

The global Biologics market size is projected to grow from US$ 101890 million in 2022 to US$ 147350 million in 2029; it is expected to grow at a CAGR of 147350 from 2023 to 2029.

North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.

This report presents a comprehensive overview, market shares, and growth opportunities of Biologics market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi

Segmentation by application
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Eli Lilly & Company
Samsung Biologics
F Hoffman La Roche
Celltrion
Addgene
Amgen
Abbvie Inc.
Sanofi
Pfizer Inc.
Merck & Co. Inc.
Novo Nordisk A/S
Johnson & Johnson Services Inc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Biologics market?

What factors are driving Biologics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Biologics market opportunities vary by end market size?

How does Biologics break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.